echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > Treat To Target, a picture to understand the "new" concept of the treatment of reflux esophagitis!

    Treat To Target, a picture to understand the "new" concept of the treatment of reflux esophagitis!

    • Last Update: 2021-04-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Only for medical professionals to read for reference.
    Reaching the standard treatment is a dynamic and constantly approaching process.

    Previous recommendations: Two or three things about the nighttime symptoms of reflux esophagitis, one picture to understand! New Year warning! In addition to three kilograms of fat, beware of reflux, "one fat destroys everything".
    Obesity is actually related to reflux esophagitis! Have you been recruited? Price cut! The first potassium ion-competitive blocker, Vonolasen, enters the national health insurance
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.